The RIO-Diabetes study, which was performed in 159 centers in 11 countries, showed that rimonabant 20 mg once daily can reduce body weight and improve cardiovascular and metabolic risk factors in ...

With rimonabant we see an improvement in HbA 1c with important reductions in weight—that is what makes it different and distinct. He believes that rimonabant has "tremendous potential" in the ...

Rimonabant has been shown to produce substantial weight loss and waist circumference reduction in nondiabetic overweight or obese patients, as well as improve their cardiovascular risk factors. Scheen ...

A little pharmacodynamics review. Rimonabant is an inverse agonist at the cannabinoid 1 (CB1) receptor. Briefly, an inverse agonist is a pharmacological agent that binds to a receptor and keeps it ...

Review the side-effects of Rimonabant as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Treatment with rimonabant may offer significant weight loss benefits for patients who are overweight or obese, according to recent results from the RIO: North America Study. The study, led by F.

Discover comprehensive details about Rimonabant, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

The anti-obesity medication rimonabant showed mixed results in slowing progression of coronary artery disease in patients with abdominal obesity and pre-existing coronary disease, according to a new ...

To investigate whether rimonabant, a cannabinoid receptor antagonist, had inhibitory effects on inflammatory reactions in human umbilical vein endothelial cells (HUVEC). Rimonabant at 1 and 10 μmol/L ...

Cincinnati, OH, March 9, 2004 - C Researchers at the University of Cincinnati College of Medicine presented results of one of the largest smoking cessation trials ever conducted in the United States, ...

An experimental pill seems to help people lose weight and quit smoking. Better yet, it seems also to have a hugely positive effect on other risk factors for heart disease and on raising good ...

In a June meeting, the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee unanimously voted against approval of the proposed weight-loss drug rimonabant due to unclear safety information and ...